Sex Differences in the Risk of Cardiovascular Diseases Associated With Diabetes
- Conditions
- Diabetes Mellitus
- Registration Number
- NCT02542774
- Lead Sponsor
- University College, London
- Brief Summary
To evaluate the risk of cardiovascular events associated with medication use for controlling blood glucose, blood pressure and cholesterol levels in men and women with diabetes treated in primary care
- Detailed Description
The management and treatment of adult diabetes is far from optimal. The most recent report from the National Diabetes Audit showed that only one in three people with diabetes are achieving recommended standards for controlling blood glucose, blood pressure and cholesterol levels; and only three in five received basic care processes to reduce their risk of diabetes-related complications such as blindness, amputation and kidney disease. Women did 15% worse than men, which may explain some of the reported higher excess risk of coronary heart disease and stroke, consequent to diabetes in women than men. More efficient and equitable care in people with diabetes could lead to substantial cost savings, and would improve the lives of women and men currently living with diabetes.
The objective of this research isto evaluate the risk of cardiovascular events associated with medication use for controlling blood glucose, blood pressure and cholesterol levels in men and women with diabetes treated in primary care.
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 80000
- Patients with diabetes at or before study entry, and participants who develop new-onset diabetes during follow-up.
- Age ≥ 18 years
- Data collected in the period 1997-2010
- Minimum time since registration of 1 year
- Minimum of 1 year of up to standard data (CPRD quality standard)
• None
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method First occurrence of cardiovascular disease 10 years First recorded diagnosis of cardiovascular disease during follow-up: stable angina, unstable angina, myocardial infarction, unheralded coronary death, heart failure, transient ischaemic attack, ischaemic stroke, subarachnoid haemorrhage, intracerebral haemorrhage, peripheral arterial disease, abdominal aortic aneurysm, ventricular arrhythmia, cardiac arrest, or sudden cardiac death
- Secondary Outcome Measures
Name Time Method Cardiovascular mortality 10 years Composite endpoint of cardiovascular mortality
All cause mortality 10 years Composite endpoint of all cause mortality
Trial Locations
- Locations (1)
The George Institute for Global Health, Nuffield Department for Population Health, University of Oxford
🇬🇧Oxford, United Kingdom